Advances of Microbiome in Human Cancers
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: closed (30 June 2026) | Viewed by 783
Editor
Interests: cancer research; cancer diagnostics; head and neck cancer; microbiome; bioinformatics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The human microbiome—comprising trillions of bacteria, viruses, fungi, and other microbes residing in and on the body—has emerged as a key player in cancer biology. Once overlooked, it is now recognized for its influence on cancer initiation, progression, and response to therapy through mechanisms involving inflammation, immune modulation, DNA damage, and microbe-host metabolic interaction. Dysbiosis in the gut or tumor-resident microbiotas has been implicated in cancers of the colon, liver, pancreas, and beyond. As the field rapidly evolves, recent challenges related to data reproducibility and methodological consistency have underscored the need for rigorous standards and validation. This Special Issue aims to highlight recent advances in microbiome research related to human cancers, encompassing mechanistic insights and translational applications. We invite studies exploring microbial biomarkers, interactions with cancer therapies, microbiota-targeting interventions, and translational feasibility. Emphasis will also be placed on interdisciplinary approaches, standardization efforts, tumor-resident microbes, and linkage of microbiotas to clinical outcome, with the goal of advancing the microbiome’s clinical utility in oncology.
Dr. Weg M. Ongkeko
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human microbiome
- gut microbiota
- tumor-resident microbes
- translational research
- biomarkers
- computational biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
